8-K Announcements
6Material company update
May 4, 2026·SEC
Material company update
May 4, 2026·SEC
Material company update
May 4, 2026·SEC
National Health Investors, Inc.(NHI)Earnings, Financials & Key Ratios
NHI•NYSE•REIT / Real Estate
23.5× P/E·Price updated Jun 19, 2026
AboutIncorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.Show more
- Revenue$379M+12.9%
- FFO$226M+7.9%
- FFO/Share4.80+1.2%
- FFO Payout75.08%+0.5%
- FFO per Share4.80+1.2%
- NOI Margin36.7%-62.0%
- FFO Margin59.71%-4.4%
- ROE9.72%-6.3%
- ROA5.25%-2.8%
NHI Key Insights
National Health Investors, Inc. (NHI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓FFO growing 9.7% TTM
- ✓Sustainable FFO payout ratio of 75.1%
- ✓Healthy dividend yield of 5.1%
✗Weaknesses
- ✗Low NOI margin of 36.7%
- ✗Dividend payout exceeds 100% of earnings
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when NHI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NHI Price & Volume
National Health Investors, Inc. (NHI) stock price & volume — 10-year historical chart
Loading chart...
NHI Growth Metrics
National Health Investors, Inc. (NHI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years5.15%
5 Years2.61%
3 Years10.81%
TTM17.48%
Profit CAGR
10 Years-0.46%
5 Years-5.14%
3 Years28.89%
TTM4.89%
EPS CAGR
10 Years-2.65%
5 Years-0.07%
3 Years80.92%
TTM-1.59%
Return on Capital
10 Years7.53%
5 Years7.16%
3 Years8.09%
Last Year8%
NHI Recent Earnings
National Health Investors, Inc. (NHI) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 4, 2026Metric
Actual
Est
EPS
$1.24+2.5%
$1.21
Rev
$73M+4.2%
$70M
Q1 2026
Feb 26, 2026Metric
Actual
Est
EPS
$1.22+52.3%
$0.80
Rev
$70M+1.8%
$69M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$1.32+6.5%
$1.24
Rev
$90M-5.5%
$95M
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$1.22+5.2%
$1.16
Rev
$91M+6.7%
$86M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 4, 2026 | $1.24vs $1.21+2.5% | $73Mvs $70M+4.2% |
| Q1 2026 | Feb 26, 2026 | $1.22vs $0.80+52.3% | $70Mvs $69M+1.8% |
| Q4 2025 | Nov 6, 2025 | $1.32vs $1.24+6.5% | $90Mvs $95M-5.5% |
| Q3 2025 | Aug 6, 2025 | $1.22vs $1.16+5.2% | $91Mvs $86M+6.7% |
Based on last 12 quarters of dataView full earnings history →
NHI Peer Comparison
National Health Investors, Inc. (NHI) competitors in Senior housing and skilled nursing — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 OHI | 13.26B | 44.53 | 22.95 | 13.95% | 51.02% | 11.85% | 0.78 | |
 SBRA | 4.57B | 18.12 | 28.31 | 10.15% | 19.21% | 5.6% | 0.90 | |
 LTC | 1.86B | 36.37 | 14.43 | 25.26% | 39.08% | 10.9% | 0.73 | |
 CTRE | 8.76B | 37.06 | 23.61 | 108.79% | 71.55% | 8.63% | 0.22 | |
 GMRE | 94.26M | 35.74 | 115.29 | 7.08% | -8.18% | -2.31% | ||
 VTR | 38.8B | 81.61 | 151.13 | 18.47% | 4.25% | 2.08% | 1.05 | |
 WELL | 144.78B | 206.65 | 148.67 | 35.82% | 12.31% | 3.49% | 0.49 | |
 HR | 6.9B | 19.79 | -27.87 | -6.92% | -17.51% | -4.28% | 0.89 |
Compare NHI vs Peers
National Health Investors, Inc. (NHI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NHI Income Statement
National Health Investors, Inc. (NHI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 278.66M | 294.61M | 318.08M | 332.81M | 298.71M | 278.19M | 319.83M | 335.18M | 378.53M | 402.91M |
Revenue Growth % | 12.14% | 5.72% | 7.97% | 4.63% | -10.24% | -6.87% | 14.97% | 4.8% | 12.93% | 17.48% |
Property Operating Expenses | 960K | 1.17M | 5.8M | 9.65M | 11.64M | 9.79M | 11.51M | 11.16M | 239.6M | 156.08M |
Net Operating Income (NOI) | 277.7M▲ 0% | 293.45M▲ 5.7% | 312.28M▲ 6.4% | 323.16M▲ 3.5% | 287.08M▼ 11.2% | 268.41M▼ 6.5% | 308.32M▲ 14.9% | 324.02M▲ 5.1% | 138.93M▼ 57.1% | 246.83M▲ 0% |
NOI Margin % | 99.66% | 99.6% | 98.18% | 97.1% | 96.1% | 96.48% | 96.4% | 96.67% | 36.7% | 61.26% |
Operating Expenses | 80.84M | 85.37M | 92.27M | 98.24M | 101.83M | 135.64M | 129.53M | 140.16M | -55.9M | 51.44M |
G&A Expenses | 12.71M | 12.86M | 13.91M | 14.56M | 19.34M | 25.32M | 19.82M | 21.79M | 0 | 13.66M |
EBITDA | 277.78M | 299.03M | 296.83M | 308.07M | 266.05M | 203.65M | 248.76M | 255.3M | 278.67M | 282.32M |
EBITDA Margin % | 99.68% | 101.5% | 93.32% | 92.57% | 89.06% | 73.2% | 77.78% | 76.17% | 73.62% | 70.07% |
Depreciation & Amortization | 79.96M | 89.79M | 76.82M | 83.15M | 80.8M | 70.88M | 69.97M | 71.44M | 83.84M | 86.93M |
D&A / Revenue % | 28.7% | 30.48% | 24.15% | 24.98% | 27.05% | 25.48% | 21.88% | 21.31% | 22.15% | 21.57% |
Operating Income | 197.81M▲ 0% | 209.24M▲ 5.8% | 220.01M▲ 5.1% | 224.92M▲ 2.2% | 185.25M▼ 17.6% | 132.77M▼ 28.3% | 178.79M▲ 34.7% | 183.86M▲ 2.8% | 194.83M▲ 6.0% | 195.39M▲ 0% |
Operating Margin % | 70.99% | 71.02% | 69.17% | 67.58% | 62.02% | 47.72% | 55.9% | 54.85% | 51.47% | 48.49% |
Interest Expense | 0 | 49.05M | 56.3M | 0 | 48.11M | 42.44M | 55.51M | 56.12M | 57.37M | 3M |
Interest Coverage | - | 4.08x | 3.80x | - | 3.33x | 2.54x | 3.42x | 3.43x | 3.45x | - |
Non-Operating Income | -4.05M | 4.2M | 6.04M | -9.93M | 25.11M | 24.91M | -11.1M | -8.86M | -3.33M | -6.9M |
Pretax Income | 159.37M▲ 0% | 154.33M▼ 3.2% | 160.45M▲ 4.0% | 185.31M▲ 15.5% | 112.03M▼ 39.5% | 65.41M▼ 41.6% | 134.38M▲ 105.4% | 136.59M▲ 1.6% | 140.79M▲ 3.1% | 146.72M▲ 0% |
Pretax Margin % | 57.19% | 52.39% | 50.44% | 55.68% | 37.5% | 23.51% | 42.02% | 40.75% | 37.19% | 36.42% |
Income Tax | 0 | -9.17M | 0 | 0 | 66K | -89K | 0 | -45K | 0 | 0 |
Effective Tax Rate % | 0% | -5.94% | 0% | 0% | 0.06% | -0.14% | 0% | -0.03% | 0% | 0% |
Net Income | 159.37M▲ 0% | 154.33M▼ 3.2% | 160.46M▲ 4.0% | 185.13M▲ 15.4% | 111.8M▼ 39.6% | 66.4M▼ 40.6% | 135.65M▲ 104.3% | 137.99M▲ 1.7% | 142.18M▲ 3.0% | 148.11M▲ 0% |
Net Margin % | 57.19% | 52.39% | 50.45% | 55.62% | 37.43% | 23.87% | 42.41% | 41.17% | 37.56% | 36.76% |
Net Income Growth % | 5.16% | -3.16% | 3.97% | 15.37% | -39.61% | -40.61% | 104.29% | 1.72% | 3.04% | 4.89% |
Funds From Operations (FFO) | 239.33M▲ 0% | 244.12M▲ 2.0% | 237.27M▼ 2.8% | 268.28M▲ 13.1% | 192.6M▼ 28.2% | 137.28M▼ 28.7% | 205.63M▲ 49.8% | 209.43M▲ 1.8% | 226.02M▲ 7.9% | 235.04M▲ 0% |
FFO Margin % | 85.89% | 82.86% | 74.59% | 80.61% | 64.48% | 49.35% | 64.29% | 62.48% | 59.71% | 58.34% |
FFO Growth % | 0.7% | 2% | -2.81% | 13.07% | -28.21% | -28.72% | 49.78% | 1.85% | 7.92% | 41.27% |
FFO per Share | 5.82 | 5.80 | 5.43 | 6.00 | 4.21 | 3.06 | 4.74 | 4.75 | 4.80 | 4.84 |
FFO Payout Ratio % | 63.95% | 67.75% | 75.75% | 72.53% | 94.96% | 117.84% | 75.98% | 74.73% | 75.08% | 54.7% |
EPS (Diluted) | 3.87▲ 0% | 3.67▼ 5.2% | 2.38▼ 35.1% | 3.03▲ 27.3% | 1.36▼ 55.1% | 0.51▼ 62.5% | 3.13▲ 513.7% | 3.13▲ 0.0% | 3.02▼ 3.5% | 3.05▲ 0% |
EPS Growth % | 0% | -5.17% | -35.15% | 27.31% | -55.12% | -62.5% | 513.73% | 0% | -3.51% | -1.59% |
EPS (Basic) | 3.90 | 3.68 | 2.40 | 3.03 | 1.36 | 0.52 | 3.13 | 3.14 | 3.03 | - |
Diluted Shares Outstanding | 41.15M | 42.09M | 43.7M | 44.7M | 45.73M | 44.79M | 43.39M | 44.1M | 47.05M | 48.55M |
NHI Balance Sheet
National Health Investors, Inc. (NHI) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 2.55B | 2.75B | 3.04B | 3.12B | 2.84B | 2.51B | 2.49B | 2.61B | 2.8B | 2.89B |
Asset Growth % | 5.92% | 8.04% | 10.6% | 2.57% | -9.02% | -11.68% | -0.76% | 5.06% | 6.98% | 29.02% |
Real Estate & Other Assets | -2.53B | -2.73B | 304.27M | 302.21M | 2.32B | 2.12B | 2.11B | 2.22B | 6.7M | 0 |
PP&E (Net) | 2.29B | 2.37B | 2.56B | 2.67B | 0 | 0 | 0 | 0 | 0 | 0 |
Investment Securities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 0 |
Total Current Assets | 247.09M | 368.02M | 177.58M | 150.85M | 514.79M | 383.01M | 375.19M | 396.91M | 310.22M | 104.25M |
Cash & Equivalents | 3.06M | 4.66M | 5.21M | 43.34M | 37.41M | 19.29M | 22.35M | 24.29M | 19.62M | 24.95M |
Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
Other Current Assets | 5.01M | 5.25M | 83.11M | 9.21M | 68.47M | 45.53M | 7.27M | 2.21M | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.15B |
Total Liabilities | 1.22B | 1.36B | 1.54B | 1.6B | 1.32B | 1.22B | 1.21B | 1.23B | 1.26B | 1.36B |
Total Debt | 1.17B | 1.29B | 1.44B | 1.51B | 1.25B | 1.15B | 1.14B | 1.15B | 1.16B | 0 |
Net Debt | 1.16B | 1.29B | 1.44B | 1.46B | 1.21B | 1.13B | 1.11B | 1.12B | 1.14B | -24.95M |
Long-Term Debt | 1.17B | 1.28B | 1.44B | 1.5B | 1.24B | 1.11B | 890.05M | 814.84M | 1.04B | 0 |
Short-Term Borrowings | 0 | 0 | 0 | 7.15M | 0 | 42M | 245M | 331.2M | 125M | 0 |
Capital Lease Obligations | 0 | 10.64M | 0 | 0 | 8.84M | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 56.93M | 68.54M | 69.7M | 75.01M | 70.17M | 112.01M | 324.38M | 414.35M | 125M | 5.21M |
Accounts Payable | 16.3M | 19.89M | 22.88M | 18.04M | 23.18M | 25.91M | 34.3M | 37.76M | 0 | 0 |
Deferred Revenue | -1.15B | 5.95M | 0 | 0 | 5.72M | 5.05M | 6.01M | 4.28M | 5M | 5.21M |
Other Liabilities | 1.92M | 0 | 30.39M | 23.25M | 0 | 0 | 0 | 0 | 88.17M | 1.35B |
Total Equity | 2.46B▲ 0% | 2.67B▲ 8.2% | 1.5B▼ 43.8% | 1.52B▲ 1.6% | 1.52B▼ 0.4% | 1.29B▼ 15.0% | 1.27B▼ 1.2% | 1.39B▲ 8.7% | 1.54B▲ 11.2% | 1.52B▲ 0% |
Equity Growth % | 6.19% | 8.2% | -43.82% | 1.65% | -0.39% | -14.97% | -1.23% | 8.72% | 11.17% | 55.21% |
Shareholders Equity | 1.32B | 1.39B | 1.5B | 1.51B | 1.51B | 1.27B | 1.25B | 1.37B | 1.52B | 1.51B |
Minority Interest | 1.14B | 1.28B | 621K | 10.71M | 9.9M | 19.68M | 20.09M | 18.7M | 18.36M | 9.92M |
Common Stock | 415K | 427K | 446K | 452K | 459K | 434K | 434K | 457K | 483K | 0 |
Additional Paid-in Capital | 1.29B | 1.37B | 1.51B | 1.54B | 1.59B | 1.6B | 1.6B | 1.74B | 1.92B | 0 |
Retained Earnings | 32.6M | 18.07M | -5.33M | 0 | -84.56M | 2.33B | 2.47B | 2.6B | -401.65M | 2.79B |
Preferred Stock | 32.6M | 18.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Return on Assets (ROA) | 6.44% | 5.83% | 5.54% | 6.01% | 3.75% | 2.48% | 5.43% | 5.41% | 5.25% | 5.35% |
Return on Equity (ROE) | 6.66% | 6.02% | 7.7% | 12.26% | 7.36% | 4.73% | 10.58% | 10.38% | 9.72% | 9.78% |
Debt / Assets | 45.83% | 46.98% | 47.46% | 48.28% | 44.09% | 45.76% | 45.61% | 43.84% | 41.61% | 0% |
Debt / Equity | 0.47x | 0.48x | 0.96x | 0.99x | 0.83x | 0.89x | 0.89x | 0.83x | 0.76x | 0.00x |
Net Debt / EBITDA | 4.19x | 4.31x | 4.85x | 4.75x | 4.56x | 5.54x | 4.47x | 4.39x | 4.11x | -0.09x |
Book Value per Share | 59.89 | 63.36 | 34.28 | 34.07 | 33.17 | 28.80 | 29.36 | 31.41 | 32.73 | 31.36 |
NHI Cash Flow Statement
National Health Investors, Inc. (NHI) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 197.32M | 207.87M | 240.96M | 232.15M | 210.86M | 185.34M | 184.45M | 208.17M | 240.23M | 246.77M |
Operating CF Growth % | 11.35% | 5.34% | 15.92% | -3.65% | -9.17% | -12.1% | -0.48% | 12.86% | 15.4% | 63.82% |
Operating CF / Revenue % | 70.81% | 70.56% | 75.75% | 69.75% | 70.59% | 66.62% | 57.67% | 62.11% | 63.46% | 61.25% |
Net Income | 159.37M | 154.33M | 160.45M | 185.31M | 111.97M | 65.5M | 134.38M | 137.99M | 142.18M | 148.11M |
Depreciation & Amortization | 72.96M | 75.79M | 76.82M | 83.15M | 80.8M | 70.88M | 69.97M | 74.34M | 83.84M | 88.38M |
Stock-Based Compensation | 2.61M | 2.49M | 3.65M | 3.06M | 8.41M | 8.61M | 4.61M | 0 | 0 | 0 |
Other Non-Cash Items | -27.28M | -30.02M | -19.48M | -32.64M | 39.16M | 43.04M | -27.8M | -1.6M | 6.95M | 4.07M |
Working Capital Changes | -2.46M | -571K | 18.7M | -6.74M | -438K | -2.7M | 3.29M | -2.56M | 7.26M | 6.29M |
Cash from Investing | -163.85M | -250.29M | -342.52M | -89.71M | 185.28M | 197.94M | -11.63M | -191.55M | -271.07M | -299.07M |
Acquisitions (Net) | 0 | 0 | 643K | -875K | -187.54M | 11.74M | 0 | 1.17M | 1.75M | 1.75M |
Purchase of Investments | -217.76M | -238.75M | -327.42M | 0 | -119.12M | -86.17M | 0 | -202.61M | -345.18M | -363.1M |
Sale of Investments | 18.18M | 4.35M | 2.9M | 0 | 306.65M | 288.17M | 0 | 25.63M | 92.33M | 82.97M |
Other Investing | -6.68M | -102.64M | -643K | -88.68M | 185.34M | -11.17M | -7.89M | 0 | 0 | 0 |
Cash from Financing | -35.05M | 44.26M | 107.32M | -111.76M | -402.99M | -401.25M | -169.72M | -14.74M | 23.96M | -60.03M |
Dividends Paid | -153.04M | -165.39M | -179.74M | -194.58M | -182.9M | -161.77M | -156.24M | -156.51M | -169.7M | -173.02M |
Common Dividends | -153.04M | -165.39M | -179.74M | -194.58M | -182.9M | -161.77M | -156.24M | -156.51M | -169.7M | -128.58M |
Debt Issuance (Net) | -1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -1000K | 1000K | 1000K | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | -151.95M | 0 | 0 | 0 | 0 |
Other Financing | 57.49M | -141.01M | -1.06M | -6.1M | -68.45M | 5.86M | -1.05M | -7.9M | -2.14M | -6.49M |
Net Change in Cash | -1.57M▲ 0% | 1.84M▲ 216.8% | 5.76M▲ 213.4% | 30.67M▲ 432.8% | -6.86M▼ 122.4% | -17.97M▼ 162.0% | 3.1M▲ 117.3% | 1.94M▼ 37.4% | -4.67M▼ 340.2% | -110.06M▲ 0% |
Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 57K | 2.21M | 2.27M |
Cash at Beginning | 4.64M | 8.07M | 9.91M | 15.67M | 46.34M | 39.48M | 21.52M | 22.35M | 24.29M | 19.62M |
Cash at End | 3.06M | 9.91M | 15.67M | 46.34M | 39.48M | 21.52M | 24.62M | 24.29M | 19.62M | 24.95M |
Free Cash Flow | 21.98M▲ 0% | 60.22M▲ 174.0% | 222.96M▲ 270.2% | 231.99M▲ 4.1% | 210.79M▼ 9.1% | 180.71M▼ 14.3% | 180.71M▼ 0.0% | 192.44M▲ 6.5% | 220.26M▲ 14.5% | 226.1M▲ 0% |
FCF Growth % | 111.58% | 173.97% | 270.21% | 4.05% | -9.14% | -14.27% | -0% | 6.49% | 14.46% | 13.93% |
FCF / Revenue % | 7.89% | 20.44% | 70.09% | 69.71% | 70.57% | 64.96% | 56.5% | 57.41% | 58.19% | 56.12% |
NHI Key Ratios
National Health Investors, Inc. (NHI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
FFO per Share | 5.82 | 5.8 | 5.43 | 6 | 4.21 | 3.06 | 4.74 | 4.75 | 4.8 | 4.84 |
FFO Payout Ratio | 63.95% | 67.75% | 75.75% | 72.53% | 94.96% | 117.84% | 75.98% | 74.73% | 75.08% | 54.7% |
NOI Margin | 99.66% | 99.6% | 98.18% | 97.1% | 96.1% | 96.48% | 96.4% | 96.67% | 36.7% | 61.26% |
Net Debt / EBITDA | 4.19x | 4.31x | 4.85x | 4.75x | 4.56x | 5.54x | 4.47x | 4.39x | 4.11x | -0.09x |
Debt / Assets | 45.83% | 46.98% | 47.46% | 48.28% | 44.09% | 45.76% | 45.61% | 43.84% | 41.61% | 0% |
Interest Coverage | - | 4.08x | 3.80x | - | 3.33x | 2.54x | 3.42x | 3.43x | 3.45x | - |
Book Value / Share | 59.89 | 63.36 | 34.28 | 34.07 | 33.17 | 28.8 | 29.36 | 31.41 | 32.73 | 31.36 |
Revenue Growth | 12.14% | 5.72% | 7.97% | 4.63% | -10.24% | -6.87% | 14.97% | 4.8% | 12.93% | 17.48% |
Related:NHI Dividend History·NHI Revenue History·NHI Price History·NHI P/E History·NHI Financial Ratios·NHI Institutional Holders
NHI SEC Filings & Documents
National Health Investors, Inc. (NHI) SEC filings — annual & quarterly reports (10-K, 10-Q)
NHI Frequently Asked Questions
National Health Investors, Inc. (NHI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
National Health Investors, Inc. (NHI) reported $402.9M in revenue for fiscal year 2025. This represents a 305% increase from $99.4M in 1996.
National Health Investors, Inc. (NHI) grew revenue by 12.9% over the past year. This is steady growth.
Yes, National Health Investors, Inc. (NHI) is profitable, generating $148.1M in net income for fiscal year 2025 (37.6% net margin).
Dividend & Returns
Yes, National Health Investors, Inc. (NHI) pays a dividend with a yield of 5.09%. This makes it attractive for income-focused investors.
National Health Investors, Inc. (NHI) has a return on equity (ROE) of 9.7%. This is below average, suggesting room for improvement.
Industry Metrics
National Health Investors, Inc. (NHI) generated Funds From Operations (FFO) of $235.0M in the trailing twelve months. FFO is the primary profitability metric for REITs.
National Health Investors, Inc. (NHI) offers a 5.09% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.